Figures & data
Figure 1 Study protocol: schematic representation of the exposed and non-exposed buttock areas used for MED determination, biopsy and blister collection. D0 is Day 0 of the study before the start of La1 supplementation, D57, D60 and D66 are Day 1, 4 and 10 after UV exposure, respectively.
Figure 2 Representative immunohistochemical staining for three antigens, before treatment (BT) or on different days after UV exposure. Bars = 100 µm.
Figure 3 Results from MECLR: mean cpm ratios from exposed versus non-exposed skin samples. The ratios were calculated from the 54 volunteers (A) or from the UV-sensitive (UVS) and UV-resistant (UVR) subjects (B) distributed among the La1 and placebo groups. *** Statistically significant differences at p < 0.001; ** statistically significant differences at p < 0.01; * statistically significant differences at p < 0.05 between exposed and non-exposed sides. BT: before treatment.
